ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)
NCT05507645
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1446
Enrollment
OTHER
Sponsor class
Conditions
Ischemic Stroke
Mild
Thrombosis
Interventions
DRUG:
Recombinant Human Prourokinase for Injection (rhPro-UK)
DRUG:
standard medical treatment
Sponsor
Beijing Tiantan Hospital